YC
cbdMD, Inc.
YCBD · AMEX
$0.46 +0.26% (+$0.00)
1M -4.49%
Market Cap $4.83M
P/E Ratio -
Div. Yield -
ROE 34.25%
Bulios Fair Price
$0.51
10.8% upside
Current Price
$0.46
Undervalued Fair Value Overvalued
According to Bulios Fair Price, YCBD is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.59x
P/S 0.23x
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 38.74%
Rev. growth 18.46%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 13.87%
Gross margin 56.48%
FCF margin 2,990.70%
Quality
15 /100
Poor ROA 21.97%
ROIC 27.85%
Asset turnover 1.59x
Debt
100 /100
Low Current ratio 2.50x
Debt/Equity 0.27x
Debt/Assets N/A
Stability
45 /100
Moderate EPS volatility 24.94%
Beta 2.17x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about YCBD
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
T. Ronan Kennedy
Employees
42
Headquarters
Charlotte
Upcoming events
18 DEC
Earnings
Upcoming earnings report